Glp3 Reta 20mg

Lifegen Peptides Retatrutide

Retatrutide is a novel triple agonist research peptide targeting GLP-1, GIP, and glucagon receptors. It is widely studied in laboratory models for its effects on metabolic regulation, weight management pathways, and energy homeostasis.

Key Research Areas: • Metabolic regulation and glucose homeostasis • Appetite suppression and satiety signaling • Body composition and fat metabolism models • Energy expenditure and thermogenesis pathways • Multi-receptor incretin and glucagon signaling • Long-term metabolic health and insulin sensitivity • Synergistic effects with related peptide compounds

Product Specifications: • Purity: ≥99% (HPLC verified, third-party tested – COA available for download) • Form: Lyophilized white powder in sterile glass vial • Appearance: Dry vial with rubber stopper and aluminum crimp seal • Storage: Refrigerate at 2–8°C; protect from light and moisture for maximum stability

Intended Use

Sold strictly for laboratory research and scientific investigation only. Not for human consumption, therapeutic, or diagnostic purposes. Researchers must follow all institutional and regulatory guidelines.

Disclaimer

Lifegen Peptides Retatrutide is intended exclusively for research use. These products have not been evaluated by the FDA and are not approved for human or veterinary use. Buyers assume full responsibility for compliance with all applicable laws and regulations.